Home
Bioprocessing
Chromatography
Drug Delivery
Excipients
Formulation Development
Microbiology
Spectroscopy
Articles
Issue Archives
Whitepapers / App Notes / eBooks
Infographics
Facility Tour
CGT Circuit
News
Industry News
Supplier News
All News
Products
Featured Products
New Products
Analytical Equipment
Formulation Development
Pharmaceutical Manufacturing
Excipients
All Other Products
QC Corner
Webinars
Videos
Documentaries
Company Profiles
Events
Register
Sign In
Welcome Guest
Sign In
Register
The presence and persistence of ERCC-1 positive circulating tumor cells predicts worse prognosis in primary ovarian cancer patients
The presence and persistence of ERCC-1 positive circulating tumor cells predicts worse prognosis in primary ovarian cancer patients
Monday, May 23, 2016
Tweet
Transcript
Embed
Email
Bookmark
Chapters
Introduction
Resistance to platinum-based chemotherapy
Background
Patients and Methods
Results
Capacity of Circulating Tumor Cells
Technologies in Liquid Biopsy
Bioinformatics Tool
Results
Plans for the Future
CTC’s in Screening?
Conclusion
No transcript for this webinar
More Information
Contact Us
Videos
Maximizing the Potential of 3D Organoid Research ...
Monday, June 10, 2024
Sterility Testing Workflow Solutions
Thursday, June 06, 2024
Watch Video: Alessandro Paolini Talks about the ...
Wednesday, June 05, 2024
Watch Video: Paolo Simonazzi Talks about the ...
Wednesday, June 05, 2024
On-Demand Webinar: Achieving EU GMP Annex 1 ...
Wednesday, May 15, 2024
Page
<<
<
1
2
3
4
>
>>